|
Diabetes, Vol 49, Issue 5 810-819, Copyright © 2000 by American Diabetes Association
Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase
AT Cheung, J Wang, D Ree, JK Kolls and M Bryer-Ash
Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
The molecular mechanism whereby tumor necrosis factor-alpha (TNF-alpha)
induces insulin resistance in obesity is not well understood. Previously,
we have shown that inhibition of TNF-alpha improved hepatic insulin
sensitivity in obese Zucker rats without altering the tyrosine
phosphorylation of liver insulin receptors (IRs), which indicates that the
TNF-alpha and insulin-signaling cascades interact distally to the IR. To
assess the effects of TNF-alpha on signaling molecules downstream from the
IR, we analyzed the tyrosine phosphorylation patterns of liver homogenate
proteins from TNF-alpha-neutralized fa/fa rats and showed that focal
adhesion kinase (FAK) was consistently hyperphosphorylated (4.5-fold).
Moreover, intravenous insulin increased hepatic FAK phosphorylation in a
time-dependent manner in Sprague-Dawley rats, which suggests that TNF-alpha
may induce hepatic insulin resistance by preventing FAK phosphorylation in
response to insulin treatment. To explore the cellular mechanism whereby
TNF-alpha regulates phosphorylation of FAK in the liver, we measured c-Src
kinase activity and the abundance of 3 major protein tyrosine phosphatases
(PTPs) (PTP-1B, leukocyte antigen-related tyrosine phosphatase [LAR], and
src homology 2 domain-containing protein-tyrosine phosphatase [SHPTP-2]) in
liver homogenates from obese Zucker rats after TNF-alpha blockade. Hepatic
c-Src kinase activity was unaltered, but LAR protein was reduced by 75%. In
addition, TNF-alpha blockade reduced hepatic PTP activity toward tyrosine
phosphorylated FAK by 70%, and this was accounted for by immunodepletion of
LAR. Incubation of HepG2 cells with TNF-alpha increased LAR protein levels
in a dose-dependent manner. Additionally, pretreatment with TNF-alpha
abolished insulin-stimulated tyrosine phosphorylation of FAK in HepG2 cells
but had no effect on IR tyrosine phosphorylation or expression. These data
suggest that TNF-alpha promotes LAR expression and thus prevents
insulin-mediated tyrosine phosphorylation of FAK. This probably represents
the interface between TNF-alpha and insulin signaling in the liver.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Frasca, G. Pandini, R. Malaguarnera, A. Mandarino, R. L. Messina, L. Sciacca, A. Belfiore, and R. Vigneri
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling
J. Biol. Chem.,
September 7, 2007;
282(36):
26077 - 26088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nieto-Vazquez, S. Fernandez-Veledo, C. de Alvaro, C. M. Rondinone, A. M. Valverde, and M. Lorenzo
Protein-Tyrosine Phosphatase 1B-Deficient Myocytes Show Increased Insulin Sensitivity and Protection Against Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance
Diabetes,
February 1, 2007;
56(2):
404 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huang, M. Khoe, D. Ilic, and M. Bryer-Ash
Reduced Expression of Focal Adhesion Kinase Disrupts Insulin Action in Skeletal Muscle Cells
Endocrinology,
July 1, 2006;
147(7):
3333 - 3343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kampf, B. Bodin, O. Kallskog, C. Carlsson, and L. Jansson
Marked Increase in White Adipose Tissue Blood Perfusion in the Type 2 Diabetic GK Rat
Diabetes,
September 1, 2005;
54(9):
2620 - 2627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Knobler and A. Schattner
TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad
QJM,
January 1, 2005;
98(1):
1 - 6.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog
Diabetes,
October 1, 2003;
52(10):
2453 - 2460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gum, L. L. Gaede, M. A. Heindel, J. F. Waring, J. M. Trevillyan, B. A. Zinker, M. E. Stark, D. Wilcox, M. R. Jirousek, C. M. Rondinone, et al.
Antisense Protein Tyrosine Phosphatase 1B Reverses Activation of p38 Mitogen-Activated Protein Kinase in Liver of ob/ob Mice
Mol. Endocrinol.,
June 1, 2003;
17(6):
1131 - 1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes
Diabetes,
December 1, 2002;
51(12):
3391 - 3399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huang, A. T. Cheung, J. T. Parsons, and M. Bryer-Ash
Focal Adhesion Kinase (FAK) Regulates Insulin-stimulated Glycogen Synthesis in Hepatocytes
J. Biol. Chem.,
May 10, 2002;
277(20):
18151 - 18160.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|